Progyny, Inc. (PGNY)
- Previous Close
20.89 - Open
20.74 - Bid 14.80 x 200
- Ask 26.39 x 200
- Day's Range
20.49 - 20.81 - 52 Week Range
13.39 - 30.42 - Volume
786,006 - Avg. Volume
1,521,895 - Market Cap (intraday)
1.759B - Beta (5Y Monthly) 1.38
- PE Ratio (TTM)
36.00 - EPS (TTM)
0.57 - Earnings Date Aug 4, 2025 - Aug 8, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
26.25
Progyny, Inc., a benefits management company, provides fertility, family building, and women's health benefits solutions in the United States. The company offers fertility benefits solutions, such as differentiated benefits plan design that includes smart cycle treatment bundle; personalized concierge-style member support services; and a selective network of fertility specialists. It also offers Progyny Rx, an integrated pharmacy benefits solution that provides access to the medications needed during their treatment and offers care management services. In addition, the company offers assistance service program where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.
www.progyny.comRecent News: PGNY
View MorePerformance Overview: PGNY
Trailing total returns as of 5/23/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: PGNY
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: PGNY
View MoreValuation Measures
Market Cap
1.76B
Enterprise Value
1.53B
Trailing P/E
36.00
Forward P/E
13.16
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.56
Price/Book (mrq)
3.77
Enterprise Value/Revenue
1.26
Enterprise Value/EBITDA
19.94
Financial Highlights
Profitability and Income Statement
Profit Margin
4.33%
Return on Assets (ttm)
5.99%
Return on Equity (ttm)
10.11%
Revenue (ttm)
1.21B
Net Income Avi to Common (ttm)
52.5M
Diluted EPS (ttm)
0.57
Balance Sheet and Cash Flow
Total Cash (mrq)
256.12M
Total Debt/Equity (mrq)
6.19%
Levered Free Cash Flow (ttm)
200.38M